| Dr Meijuan Zhao, MD | |
|
55 Fruit St Yaw 2100, Orthopaedic Associates, Boston, MA 02114-2696 | |
| (617) 726-8530 | |
| (617) 724-8532 |
| Full Name | Dr Meijuan Zhao |
|---|---|
| Gender | Female |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 35 Years |
| Location | 55 Fruit St Yaw 2100, Boston, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013999754 | NPI | - | NPPES |
| 468194 | Other | MA | TUFTS HEALTH PLAN |
| 2100941 | Medicaid | MA | |
| J28567 | Other | MA | BCBS MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 223585 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Massachusetts General Hospital | Boston, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Massachusetts General Physicians Organization Inc | 2466365820 | 3085 |
News Archive
Scientists at the University of Basel discovered a fundamental new mechanism explaining the inadequate immune defense against chronic viral infection. These results may open up new avenues for vaccine development. They have been published in the journal "Science Immunology".
Researchers at the University of Rochester Medical Center have coined a simple formula that predicts how well a certain chemotherapy will work for targeting brain and other nervous system cancers. The formula, which publishes mid-July in Cancer Chemotherapy and Pharmacology, is pegged to two important proteins that compose such hard-to-kill tumors - one of which, ironically, makes them so drug-resistant in the first place.
A new drug to treat hepatitis C that costs $1,000 a pill has caused rising concern among insurers and state Medicaid programs. It has now also spurred interest from Democratic congressmen whose queries about the drug prompted a sell-off in biotechnology stocks on Friday. Three Democratic members of the House Energy and Commerce Committee have demanded that Gilead Sciences, the developer, justify the price of its drug, which is called Sovaldi (Pollack, 3/21).
Julie Miller is a key part of an extensive effort at Cedars-Sinai to increase awareness of and support for women's cancer research. She not only has registered to participate in clinical research, but she's also lacing up her running shoes.
Lumosity, the leading brain training company, today announced a new web-based, big data methodology for conducting human cognitive performance research. Lumosity's research platform, the Human Cognition Project, contains the world's largest and continuously growing dataset of human cognitive performance, which currently includes more than 40 million people who have been tracked for up to 6 years.
› Verified 6 days ago
| Entity Name | Massachusetts General Physicians Organization Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801874573 PECOS PAC ID: 2466365820 Enrollment ID: O20031111000434 |
News Archive
Scientists at the University of Basel discovered a fundamental new mechanism explaining the inadequate immune defense against chronic viral infection. These results may open up new avenues for vaccine development. They have been published in the journal "Science Immunology".
Researchers at the University of Rochester Medical Center have coined a simple formula that predicts how well a certain chemotherapy will work for targeting brain and other nervous system cancers. The formula, which publishes mid-July in Cancer Chemotherapy and Pharmacology, is pegged to two important proteins that compose such hard-to-kill tumors - one of which, ironically, makes them so drug-resistant in the first place.
A new drug to treat hepatitis C that costs $1,000 a pill has caused rising concern among insurers and state Medicaid programs. It has now also spurred interest from Democratic congressmen whose queries about the drug prompted a sell-off in biotechnology stocks on Friday. Three Democratic members of the House Energy and Commerce Committee have demanded that Gilead Sciences, the developer, justify the price of its drug, which is called Sovaldi (Pollack, 3/21).
Julie Miller is a key part of an extensive effort at Cedars-Sinai to increase awareness of and support for women's cancer research. She not only has registered to participate in clinical research, but she's also lacing up her running shoes.
Lumosity, the leading brain training company, today announced a new web-based, big data methodology for conducting human cognitive performance research. Lumosity's research platform, the Human Cognition Project, contains the world's largest and continuously growing dataset of human cognitive performance, which currently includes more than 40 million people who have been tracked for up to 6 years.
› Verified 6 days ago
| Entity Name | The General Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023049236 PECOS PAC ID: 6507803806 Enrollment ID: O20080313000351 |
News Archive
Scientists at the University of Basel discovered a fundamental new mechanism explaining the inadequate immune defense against chronic viral infection. These results may open up new avenues for vaccine development. They have been published in the journal "Science Immunology".
Researchers at the University of Rochester Medical Center have coined a simple formula that predicts how well a certain chemotherapy will work for targeting brain and other nervous system cancers. The formula, which publishes mid-July in Cancer Chemotherapy and Pharmacology, is pegged to two important proteins that compose such hard-to-kill tumors - one of which, ironically, makes them so drug-resistant in the first place.
A new drug to treat hepatitis C that costs $1,000 a pill has caused rising concern among insurers and state Medicaid programs. It has now also spurred interest from Democratic congressmen whose queries about the drug prompted a sell-off in biotechnology stocks on Friday. Three Democratic members of the House Energy and Commerce Committee have demanded that Gilead Sciences, the developer, justify the price of its drug, which is called Sovaldi (Pollack, 3/21).
Julie Miller is a key part of an extensive effort at Cedars-Sinai to increase awareness of and support for women's cancer research. She not only has registered to participate in clinical research, but she's also lacing up her running shoes.
Lumosity, the leading brain training company, today announced a new web-based, big data methodology for conducting human cognitive performance research. Lumosity's research platform, the Human Cognition Project, contains the world's largest and continuously growing dataset of human cognitive performance, which currently includes more than 40 million people who have been tracked for up to 6 years.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Meijuan Zhao, MD Po Box 9142, Charlestown, MA 02129-9142 Ph: (614) 643-2420 | Dr Meijuan Zhao, MD 55 Fruit St Yaw 2100, Orthopaedic Associates, Boston, MA 02114-2696 Ph: (617) 726-8530 |
News Archive
Scientists at the University of Basel discovered a fundamental new mechanism explaining the inadequate immune defense against chronic viral infection. These results may open up new avenues for vaccine development. They have been published in the journal "Science Immunology".
Researchers at the University of Rochester Medical Center have coined a simple formula that predicts how well a certain chemotherapy will work for targeting brain and other nervous system cancers. The formula, which publishes mid-July in Cancer Chemotherapy and Pharmacology, is pegged to two important proteins that compose such hard-to-kill tumors - one of which, ironically, makes them so drug-resistant in the first place.
A new drug to treat hepatitis C that costs $1,000 a pill has caused rising concern among insurers and state Medicaid programs. It has now also spurred interest from Democratic congressmen whose queries about the drug prompted a sell-off in biotechnology stocks on Friday. Three Democratic members of the House Energy and Commerce Committee have demanded that Gilead Sciences, the developer, justify the price of its drug, which is called Sovaldi (Pollack, 3/21).
Julie Miller is a key part of an extensive effort at Cedars-Sinai to increase awareness of and support for women's cancer research. She not only has registered to participate in clinical research, but she's also lacing up her running shoes.
Lumosity, the leading brain training company, today announced a new web-based, big data methodology for conducting human cognitive performance research. Lumosity's research platform, the Human Cognition Project, contains the world's largest and continuously growing dataset of human cognitive performance, which currently includes more than 40 million people who have been tracked for up to 6 years.
› Verified 6 days ago
John Joseph Danko, DO Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 55 Fruit St, Boston, MA 02114 Phone: 617-726-2000 | |
Dr. John-paul David Hezel, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 330 Brookline Ave, Stoneman 10, Boston, MA 02215 Phone: 617-667-7678 | |
Dr. Saurabha Bhatnagar, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 150 S Huntington Ave # 117, Boston, MA 02130 Phone: 617-232-9500 | |
Cristina A Shea, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 55 Fruit St, Boston, MA 02114 Phone: 617-952-5299 | |
Dr. Gary I Polykoff, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 15 Parkman St, Wac 340 Anesthesia Pain Management, Boston, MA 02114 Phone: 617-726-3512 Fax: 617-726-3519 | |
Lauren Elizabeth Merz, MD, MSC Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 75 Francis St, Boston, MA 02115 Phone: 617-732-5500 |